Skip to main content
Erschienen in: Osteoporosis International 9/2018

05.07.2018 | Letter to the Editor

Comments on Bergman et al.: Bisphosphonate use after clinical fracture and risk of new fracture

verfasst von: Q.-Y. Wu, F.-L. Yuan, B. Wang, X. Li

Erschienen in: Osteoporosis International | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
2.
Zurück zum Zitat Goh S (2015) Title of news article on zoledronic acid and bone density was misleading. BMJ 350:h2337CrossRefPubMed Goh S (2015) Title of news article on zoledronic acid and bone density was misleading. BMJ 350:h2337CrossRefPubMed
3.
Zurück zum Zitat Grey A, Reid IR (2006) Differences between the bisphosphonates for the prevention and treatment of osteoporosis. Ther Clin Risk Manag 2:77–86PubMedPubMedCentral Grey A, Reid IR (2006) Differences between the bisphosphonates for the prevention and treatment of osteoporosis. Ther Clin Risk Manag 2:77–86PubMedPubMedCentral
4.
Zurück zum Zitat Prieto-Alhambra D, Nogues X, Javaid MK, Wyman A, Arden NK, Azagra R, Cooper C, Adachi JD, Boonen S, Chapurlat RD, Compston JE, Gehlbach SH, Greenspan SL, Hooven FH, Netelenbos JC, Pfeilschifter J, Rossini M, Sambrook PN, Silverman S, Siris ES, Watts NB, Díez-Pérez A (2013) An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW). Ann Rheum Dis 72:911–917CrossRefPubMed Prieto-Alhambra D, Nogues X, Javaid MK, Wyman A, Arden NK, Azagra R, Cooper C, Adachi JD, Boonen S, Chapurlat RD, Compston JE, Gehlbach SH, Greenspan SL, Hooven FH, Netelenbos JC, Pfeilschifter J, Rossini M, Sambrook PN, Silverman S, Siris ES, Watts NB, Díez-Pérez A (2013) An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW). Ann Rheum Dis 72:911–917CrossRefPubMed
5.
Zurück zum Zitat Silverman SL, Ott SM, Dell RM (2010) Bisphosphonates and atypical femoral fractures. N Engl J Med 363:1083 author reply 1084–1085 Silverman SL, Ott SM, Dell RM (2010) Bisphosphonates and atypical femoral fractures. N Engl J Med 363:1083 author reply 1084–1085
6.
Zurück zum Zitat X. Li, J.-X. Ye, M.-H. Xu, M.-D. Zhao, F.-L. Yuan, (2017) Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway. Osteoporosis International 28 (7):2221–2231 X. Li, J.-X. Ye, M.-H. Xu, M.-D. Zhao, F.-L. Yuan, (2017) Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway. Osteoporosis International 28 (7):2221–2231
Metadaten
Titel
Comments on Bergman et al.: Bisphosphonate use after clinical fracture and risk of new fracture
verfasst von
Q.-Y. Wu
F.-L. Yuan
B. Wang
X. Li
Publikationsdatum
05.07.2018
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 9/2018
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-018-4614-6

Weitere Artikel der Ausgabe 9/2018

Osteoporosis International 9/2018 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.